KCT0008808招募中Unknown
Exploring HER2 Overexpression and its Significance as a Biomarker in pathologic T-stage of de novo Muscle-Invasive Bladder Cancer: A prospective study in Retrospective multicenter Cohort
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 174
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •The patients were recently diagnosed with urothelial cancer and had no history of urothelial cancer. Patients who underwent transurethral resection of bladder tumor at Gangneung Asan Hospital between January 2005 and December 2013.
排除标准
- •If have a upper urinary tract cancer is diagnosed
- •diagnosed metastasized carcinoma
- •If the carcinoma is not a cancer originating in the urinary tract epithelium
研究者
相似试验
已完成
不适用
Prognostic significance of HER2 expression in patients with resectable gastric cancerGastric adenocarcinomaCancerISRCTN54802594Inje University Busan Paik Hospital782
招募中
不适用
Interrelationship of Serum HER2-ECD with Pathological HER2 level (Human Epidermal Growth Factor Receptor Type2 - Extra Cellular Domain) in Operable Gastric Cancer Patients in JapaGastric CancerJPRN-UMIN000006048Shizuoka General Hospital60
已完成
不适用
Observational study of serum HER2 in HER2 positive advanced gastric cancer treated with trastuzumab in combination with capecitabine plus cisplatin(XP+H)Gastric cancerJPRN-UMIN000006445Sapporo Medical University 1st department of Internal Medicine10
Unknown
2 期
Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid TumorHER-2 Protein OverexpressionHER-2 Gene AmplificationNCT04215159Jin-Hee Ahn42
Unknown
不适用
HER2 Positive CTC in Advanced Gastric CancerHER2 Positive Advanced Gastric CancerNCT01847794Peking University50